FDA Approvals in Oncology: July-September 2023
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Category: FDA Approvals
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...